Background Before we dive into the example of adaptation/implementation, we need to ask you some basic background questions. It is important for us to understand what type of example you are submitting. Here are some key definitions to keep in mind as you move through this section:
Knowledge Product: Any tangible output from a joint learning activity that has been co-created with member countries overtime (e.g., assessment tools or guides) and made available as a global public good.
Adaptation: The modification of a generic knowledge product to align to country specific needs. Moves beyond simple translation of a generic product. This may involve some initial use (possibly as a pilot embedded within a joint learning activity) as well as updates to the product before full implementation.
Implementation: Separate from and next step after adaptation; country use of a JLN knowledge product.
1. What country are you reporting for? Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo, Democratic Republic of the Congo, Republic of the Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini (Swaziland) Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russia Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay US Minor Outlying Islands Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe
2. What is your email address in case of follow up questions (please note: this email will be used as the contact point for this submission):*
3. What JLN knowledge product did the country use? Select only one per example* A Guide to Common Requirements for National Health Insurance Information Systems Assessing Health Provider Payment Systems: A Practical Guide for Countries Moving toward UHC Assessing Health Provider Payment Systems: Analytical Team Workbook Case studies of countries that have systematically used reprioritization Connecting Health Information Systems for Better Health Consolidated list of 40 indicator reference fact sheets that can be used to measure efficiency Costing Manual Toolkit Resources Costing Manual: Online Course Costing of Health Services for Provider Payment: A Practical Manual Based on Country Costing Challenges, Trade-offs, and Solutions Costing Train the Trainer Course Materials Data Analytics for Monitoring Provider Payment Toolkit Designing Health Benefits Policies: A Country Assessment Guide; Country Assessments and Synthesized Assessment Report Determining Common Requirements for National Health Insurance Information Systems DRM Narrative Summaries E-claims Standard Empanelment Assessment Tool and Assessment Guide Empanelment: A Foundational Component of Primary Health Care Engaging the Private Sector in PHC to Achieve UHC: Advice from Implementers to Implementers Financing and Payment Models for Primary Health Care: Six Lessons from JLN Country Experience Glossary of Health Insurance Terminology Guidance and use document for the tool Guide: Making the Case for Health Health Data Dictionary (openHDD) Health Priority Setting and Resource Allocation (HePRA) Tool and Database Health Priority Setting: A Practitioner’s Handbook Inventory of DRM resources and experiences Measuring Health System Efficiency in Low- and Middle-income Countries: A Resource Guide Measuring the Performance of Primary Health Care: A Practical Guide for Translating Data into Improvement Open Quality Self-Assessment Tool Policy Dialogue Toolkit Primary Health Care (PHC) Measurement for Improvement Indicator Inventory Process Framework for Health Insurance Promoting Interoperability of Health Insurance Information Systems through a Health Data Dictionary Provider Payment Mechanisms Podcast Provider Payment Reform and Information Technology Systems; A Chicken and Egg Question for National Health Coverage Programs Regulation of Private Primary Health Care: Assessment Guide, Country Assessments and Synthesized Assessment Report Requirements for National Health Insurance Information Systems Strategic Communication for Universal Health Coverage: Planning Tool Strategic Communication for Universal Health Coverage: Practical Guide Toolkit to Develop and Strengthen Medical Audit Systems: Practical Guide by Implementers for Implementers UHC Primary Health Care Self-Assessment Tool Using Data and Evidence for Health Priority Setting: A Practitioner’s Handbook Using Health Data to Improve Universal Health Coverage: A Companion Guide for Assessing Data Use Maturity Using Health Data to Improve Universal Health Coverage: Three Case Studies Vertical Integration Diagnostic and Readiness Tool Other tool not listed
3a. You selected "other". What is the name of the knowledge product?
4. Which of the following statements are true for the JLN knowledge product mentioned above?* 5. Which of the following statements best describes the level of the health system at which you used this knowledge product?* 6. Please indicate approximately what month and year you started this process.*
MM slash DD slash YYYY
7. Please indicate approximately what month and year you completed this process*
MM slash DD slash YYYY
7. When do you plan to implement the knowledge product?*
MM slash DD slash YYYY
7. Were you originally planning to implement this knowledge product? 7. What collaborative or JLN team conducted this pilot?
8. Do you have plans to adapt or implement this knowledge product further? Section 1: Stakeholder involvement and buy-in This is section one of six. We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led your CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting & implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt & implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation & implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product This is section two of six. Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product? 4C. How often did you have either virtual or in-person contact with JLN-provided experts? 4D. How often did you have either virtual or in-person contact with non-JLN experts? 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country? 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts This is section three of six. By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation & implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy?* 6. How did this process influence organizational or governmental policy?
2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting & implementing this tool?*
Section 4: Resources This is section four of six. In this section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt and implement the knowledge product in your country.
1. What resources were used to adapt and implement this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used
2. Please describe what (if any) remote JLN technical assistance or support you received to adapt and implement the knowledge product?*
3. Please describe what (if any) in-country JLN technical assistance or support you received to adapt and implement the knowledge product?*
Section 5: Collaborative Linkage This is section five of six. In this section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A. How often did your representatives participate in face to face workshops as part of the collaborative 3B. How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C. How often did your representatives participate in virtual meetings as part of the collaborative 3D. How often did your representatives participate in webinars as part of the collaborative 3E. How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up This is the last section, section six.
1. Is there any additional information you would like to share about your experience adapting and implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in This is section one of six. We want to know how you enlisted important partners and stakeholders to make sure adaptation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led your CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation process? How did you work with stakeholders to overcome those barriers?*
6. Are there any additional concerns you have regarding buy-in for the future implementation of this knowledge product?
Section 2: Process for adapting the knowledge product Next, we want to document the process you used to adapt. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information to adapt the knowledge product??*
4A. When adapting this tool, how often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. When adapting this tool, how often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. When adapting this tool, how often did you have either virtual or in-person contact with JLN-provided experts 4D. When adapting this tool, how often did you have either virtual or in-person contact with non-JLN experts 4E. When adapting this tool, how often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main takeaways from adapting the knowledge product*
6. Were any of the takeaways surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 6. How did this process influence organizational or governmental policy?
2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt the knowledge product in your country.
1. What resources were used to adapt this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
2. Please describe what (if any) remote JLN technical assistance or support you received to adapt the knowledge product?*
3. Please describe what (if any) in-country JLN technical assistance or support you received to adapt the knowledge product?*
Section 5: Collaborative Linkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A. How often did your representatives participate in face to face workshops as part of the collaborative 3B. How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C. How often did your representatives participate in virtual meetings as part of the collaborative 3D. How often did your representatives participate in webinars as part of the collaborative 3E. How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led your CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How (if at all) did you make stakeholders understand the importance of adapting this particular knowledge product? Please write a paragraph or two in response.*
3. Were you able to get stakeholders to agree on the process to adapt the knowledge product? 3A. How were you able to get an agreed upon process?*
3A. What were the main barriers to agreeing upon a process?*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. What barriers to buy-in did you face in using this tool?
6. How (if at all) did you work with stakeholders to overcome barriers to adaptation of this knowledge product? Please write a paragraph or two in response*
Section 2: Process for adapting the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation & implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 6. How did this process influence organizational or governmental policy?
2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt the knowledge product in your country.
1. What resources were used to adapt this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt the knowledge product?*
Section 5: Collaborative Linkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for implementing the knowledge product Next, we want to document the process you used to implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 6. How did this process influence organizational or governmental policy?
2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to implement the knowledge product in your country.
1. What resources were used to implement this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting & implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt & implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation & implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation/implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 6. How did this process influence organizational or governmental policy?
2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt or implement the knowledge product in your country.
1. What resources were used to adapt/implement/pilot this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt & implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt & implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting & implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting & implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt & implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation & implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation/implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt or implement the knowledge product in your country.
1. What resources were used to adapt/implement/pilot this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt & implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt & implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting & implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting & implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt & implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation & implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation/implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt or implement the knowledge product in your country.
1. What resources were used to adapt/implement/pilot this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt & implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt & implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting & implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure adaptation and implementation of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of adapting & implementing this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to adapt & implement the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the adaptation & implementation process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation/implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt or implement the knowledge product in your country.
1. What resources were used to adapt/implement/pilot this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt & implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt & implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting & implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
Section 1: Stakeholder involvement and buy-in We want to know how you enlisted important partners and stakeholders to make sure the pilot of this knowledge product was feasible in your country. Please provide what worked well and also challenges you encountered.
1. Please tell us a little about the UHC challenge or context that led yoru CCG to this JLN knowledge product. What UHC challenge was the CCG trying to solve? Please write a paragraph or two in response.
2. How did you make stakeholders understand the importance of piloting this particular knowledge product? Please write a paragraph or two in response.*
3. How did you get stakeholders to agree on the process to pilot the knowledge product? Please write a paragraph or two in response.*
4. Which stakeholders were important for this process? Please write a paragraph or two in response.*
5. Were there any barriers to the pilot process? How did you work with stakeholders to overcome those barriers?*
Section 2: Process for adapting & implementing the knowledge product Next, we want to document the process you used to adapt & implement. When possible, please provide the step-by-step process you used.
1. What was the step-by-step process used to adapt and then implement the knowledge product? Explain how you took the JLN product and used it in your country. Please write a paragraph or two in response.*
2. How did you apply peer learning or joint learning approaches when adapting & implementing the JLN knowledge product? Please write a paragraph or two in response.*
3. What data sources did you use to collect information during implementation?*
4A. How often did you have either virtual or in-person contact with individual members of the collaborative who developed the knowledge product? 4B. How often did you have either virtual or in-person contact with JLN technical facilitator for the collaborative who developed the knowledge product 4C. How often did you have either virtual or in-person contact with JLN-provided experts 4D. How often did you have either virtual or in-person contact with non-JLN experts 4E. How often did you have either virtual or in-person contact with the Country Core Group (CCG) in your country 5. What were the main findings from adapting & implementing the knowledge product? What did you find by using the tool?*
6. Were any of the findings surprising or unexpected?*
Section 3: Longer-term improvement in UHC outcomes or impacts By better documenting adaptation and implementation, we are hoping to link JLN knowledge products to UHC changes or health system changes in your country, if applicable. In this section, we want to better understand how adaptation and implementation contributed to longer term outcomes or impacts beyond just the findings from the JLN knowledge product process itself. Put another way, we would like to document any ripple effects after you adopted and implemented the knowledge product.
What do we mean by impact? Changes in health system outcomes that you think are linked to the adaptation and implementation process. Your response will help us better understand the relationship between JLN knowledge products and health system changes.
1. Were there health system changes or impacts that resulted from adapting & implementing this JLN knowledge products?* 2. Tell us more, what are the main health system impacts or outcomes from the use of this JLN knowledge product?*
3. The adaptation/implementation of the JLN knowledge product led to (select as many as apply)* Endorsement of a new evidence-based guidelines Introducing a new method or approach to overcome a barrier to UHC Successfully implementing evidence-based guidelines Developing a new system or approach to improve services Improved clinical outcomes, financial protection, quality of services, etc Other
4. What quantitative evidence or changes in indicators (if any) supports the health system impacts you mentioned? Please be as specific as possible*
4A. Are there any data files you would like to share? 5. Did the adaptation & implementation process of the JLN knowledge product influence organizational or governmental policy? If so, how?* 2. Why do you think there were no changes?*
2. The Network Manager team will follow up on this example. When would you like us to follow up on outcomes or impacts from adapting and implementing this tool?*
Section 4: Resources In the next section, we will ask some questions about how you mobilized resources (financial resources, human resources, etc.) to adapt or implement the knowledge product in your country.
1. What resources were used to adapt/implement/pilot this knowledge product? (select all that apply) Funding or financial resources Human resources Technical assistance Other
1A. What was the source that provided the funding?
1B. What was the source that provided the human resources?
1C. What was the source that provided the technical assistance?
1D. Tell us more about the other resources used.
24. Please describe what (if any) remote JLN technical assistance or support you received to adapt & implement the knowledge product?*
25. Please describe what (if any) in-country JLN technical assistance or support you received to adapt & implement the knowledge product?*
Section 5: Collaborative LInkage In this final section, we will ask some questions about your role (if any) in the original collaborative team that created the knowledge product.
1. Did anyone on the current CCG roster participate in the collaborative workshops that created this knowledge product?* 2. Did anyone on the current CCG roster participate in the co-creation of the knowledge product?* 3A.How often did your representatives participate in face to face workshops as part of the collaborative 3B.How often did your representatives participate in piloting or implementation of a tool in another country as part of a collaborative 3C.How often did your representatives participate in virtual meetings as part of the collaborative 3D.How often did your representatives participate in webinars as part of the collaborative 3E.How often did your representatives participate in other events as part of the collaborative 4. In your opinion, how, if at all, do you think the JLN collaborative facilitated the exchange of UHC knowledge and best practices that helped you adapt & implement this tool?*
Section 6: Wrap Up 1. Is there any additional information you would like to share about your experience adapting & implementing this JLN knowledge product?*
2. Are there any supporting documents you would like to share with the JLN? 3. Is there any feedback on the JLN knowledge product you would like to share with the Network Manager team?*
